ライフサイエンスコーパス: 1H-MRS

1 1H MRS could serve as a sensitive in vivo surrogate indi

2 1H-MRS spectra were collected at baseline and after trea

3 shop participants for the use of DCE-MRI and 1H MRS in the clinical assessment of antitumor therapies

4 We measured MRI and 1H-MRS changes.

5 ecreased in relation to the pre-HSCT MRI and 1H-MRS.

6 31P-MRS and 1H-MRS of tumor extracts showed a significant decrease i

7 tamate and glutamine (Glx), were measured by 1H MRS in the left dorsolateral prefrontal cortex (l-DLP

8 Intensities of the purine resonance, by 1H MRS (7.5-8.5 ppm), and of NTP, by 31P MRS, were deter

9 In individual and group comparisons, 1H MRS described a metabolite profile in the hippocampi

10 In this study, the age-dependent 1H MRS profile of transgenic AD mice was compared to tha

11 Results for 1H-MRS did not differ significantly between patients and

12 Data from 1H MRS and phosphorus-31 (31P) MRS were acquired for dep

13 Spatially localised 1H-MRS can be used to measure total creatine non-invasiv

14 ccipital cortex by using spatially localized 1H-MRS.

15 We validated this technique by comparison of 1H-MRS values of creatine with biopsy assays in an anima

16 mance of this test and the potential role of 1H-MRS in the in-vivo assessment of placental function t

17 ny of the metabolites measured by 31P-MRS or 1H-MRS there was a dose-response relationship with aura

18 oxel proton magnetic resonance spectroscopy (1H MRS) has shown abnormalities in patients with tempora

19 ther proton magnetic resonance spectroscopy (1H MRS) measures of the low-field purine resonance, whic

20 sing proton magnetic resonance spectroscopy (1H MRS), this study assessed whether dysregulation of th

21 bral proton magnetic resonance spectroscopy (1H MRS).

22 d single-voxel proton magnetic spectroscopy (1H-MRS) at 4 Tesla to examine GABA relative to total cre

23 not been considered in proton spectroscopy (1H-MRS) studies and it has not been studied in cerebral

24 and proton magnetic resonance spectroscopy (1H-MRS) as standard follow-up after HSCT with cord blood

25 Proton magnetic resonance spectroscopy (1H-MRS) can detect a choline resonance that is largely d

26 sively with magnetic resonance spectroscopy (1H-MRS) changes in the concentrations of intracellular (

27 ed hydrogen magnetic-resonance spectroscopy (1H-MRS) on a clinical (1.5 T) magnetic-resonance-imaging

28 Proton magnetic resonance spectroscopy (1H-MRS) spectra were acquired at 3 Tesla in the anterior

29 oxel proton magnetic resonance spectroscopy (1H-MRS) studies of patients with schizophrenia have foun

30 (TE) proton magnetic resonance spectroscopy (1H-MRS) to measure skeletal muscle acetylcarnitine conce

31 used proton magnetic resonance spectroscopy (1H-MRS) to study in vivo the integrity of axonal fibers

32 ized proton magnetic resonance spectroscopy (1H-MRS).

33 with proton magnetic resonance spectroscopy (1H-MRS).

34 SV 1H-MRS provides useful biochemical information about the

35 l proton magnetic resonance spectroscopy (SV 1H-MRS), coupled with supervised pattern recognition (PR

36 and negative peaks, from a widely tested SV 1H-MRS human brain tumour database.

37 For this, we used SV 1H-MRS data with positive and negative peaks, from a wid

38 Cross-sectional design using 3-T 1H-MRS in participants recruited from university-based p

39 A long-TE 1H-MRS protocol was implemented for successful detection

40 We applied long-TE 1H-MRS to measure acetylcarnitine in endurance-trained a

41 , would be associated with a decrease in the 1H-MRS choline resonance.

42 tamate ratio, it is not clear which of these 1H-MRS indices of glutamatergic neurotransmission is alt

43 Quantitative short echo time 1H MRS identified abnormalities in 87% of patients with

44 , and 15 MRI-negative TLE patients underwent 1H MRS at an echo time of 30 msec on a 1.5-T GE Signa sc

45 nse to treatment might be predicted by using 1H MRS.

46 n GABA in similar brain regions in MDD using 1H-MRS suggest a common reduction in cortical GABA among

47 Inclusion criteria were single voxel 1H-MRS studies reporting glutamate, glutamine or Glx val

48 use models of AD that have been studied with 1H MRS, APP-PS1 mice seem to best match the neurochemica

49 a and healthy controls with 31P-MRS and with 1H-MRS.

50 easuring acetylcarnitine concentrations with 1H-MRS is feasible on clinical MR scanners and support t